Skip to main content
Year archive

Immuron Ltd — 2022 filings

All 70 regulatory filings released by Immuron Ltd (IMRN) in 2022, sourced directly from the official regulator.

70 Filings
2022 Period
2022 filings (70)
Filing Released Lang
Change in substantial holding 5 pages 1.6MB
Regulatory Filings
2022-12-29 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-12-23 English
Immuron Receives FDA Approval for Travelan IND Application 3 pages 295.9KB
Regulatory Filings
2022-12-22 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-12-05 English
Immuron Submits IND Application To FDA for Travelan 2 pages 292.6KB
Regulatory Filings
2022-12-04 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-12-01 English
Amended Constitution 52 pages 504.7KB
Regulatory Filings
2022-11-30 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-11-21 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-11-21 English
AGM Presentation 11 pages 549.4KB
Regulatory Filings
2022-11-20 English
Results of Annual General Meeting 2 pages 89.4KB
Regulatory Filings
2022-11-20 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-11-16 English
Immuron completes strategic investment in Ateria Health 3 pages 331.9KB
Regulatory Filings
2022-11-15 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-10-26 English
Immuron CEO Steven Lydeamore to present at AusBioInvest 10 pages 662.5KB
Regulatory Filings
2022-10-25 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-10-21 English
Notice of Annual General Meeting/Proxy Form 27 pages 492.3KB
Regulatory Filings
2022-10-20 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-10-13 English
IMC investment in leading gut health biotech Ateria Health 4 pages 354.4KB
Regulatory Filings
2022-10-12 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-10-04 English
Immuron Executes Travelan Clinical Trial Agreement Pharmaron 2 pages 294.9KB
Regulatory Filings
2022-10-03 English
ANNUAL REPORT
Annual Report FY 2022
2022-09-09 English
Annual Report to shareholders 169 pages 4.1MB
Regulatory Filings
2022-09-08 English
Corporate Governance Statement 7 pages 206.7KB
Regulatory Filings
2022-09-08 English
Appendix 4G 12 pages 331.8KB
Regulatory Filings
2022-09-08 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-08-31 English
Appendix 4E and Preliminary Final Report 42 pages 533.4KB
Regulatory Filings
2022-08-30 English
FY22 Results and Business Update Presentation 13 pages 903.6KB
Regulatory Filings
2022-08-30 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-08-29 English
Immuron CEO, Steven Lydeamore, to host an investor webinar 2 pages 289.6KB
Regulatory Filings
2022-08-28 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-08-19 English
Immuron Update on IMM-124E SARS-CoV-2 Research 2 pages 294.9KB
Regulatory Filings
2022-08-18 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-07-26 English
Update on IND Application for Campylobacter ETEC Therapeutic 2 pages 295.7KB
Regulatory Filings
2022-07-25 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-07-11 English
North American Travelan Sales up 494%, Global sales up 431% 2 pages 265.8KB
Regulatory Filings
2022-07-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-07-07 English
European Patent Notification on Drug Composition for CDI 2 pages 398.7KB
Regulatory Filings
2022-07-06 English
Change of Director's Interest Notice (DP) 2 pages 177.0KB
Regulatory Filings
2022-07-03 English
Notification regarding unquoted securities - IMC 6 pages 28.2KB
Regulatory Filings
2022-06-30 English
Change of Director's Interest Notice 2 pages 185.8KB
Regulatory Filings
2022-06-14 English
Notification of cessation of securities - IMC 4 pages 24.2KB
Regulatory Filings
2022-06-13 English
Delisting Announcement 2022
Delisting Announcement
2022-06-10 English
Notification of cessation of securities - IMC 4 pages 24.8KB
Regulatory Filings
2022-06-09 English
Change in substantial holding 5 pages 872.6KB
Regulatory Filings
2022-05-24 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-05-11 English
US DoD NMRC files IND application with FDA 2 pages 325.8KB
Regulatory Filings
2022-05-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-05-09 English
US DoD Uniformed Services University Clinical Update 3 pages 311.4KB
Regulatory Filings
2022-05-08 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-05-05 English
Appointment of Mr Steven Lydeamore as Chef Executive Officer 3 pages 303.1KB
Regulatory Filings
2022-05-04 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-04-27 English
Immuron Q3 Global Sales up 216% YoY 3 pages 277.9KB
Regulatory Filings
2022-04-26 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-04-19 English
Immuron new MTEC project proposal 3 pages 355.7KB
Regulatory Filings
2022-04-18 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-03-16 English
Appointment of Paul Brennan as Non-Executive Director 2 pages 260.5KB
Regulatory Filings
2022-03-15 English
Initial Director's Interest Notice 2 pages 236.1KB
Regulatory Filings
2022-03-15 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-02-25 English
Half Yearly Report and Accounts 28 pages 3.4MB
Regulatory Filings
2022-02-24 English
Change in substantial holding 5 pages 845.7KB
Regulatory Filings
2022-01-23 English
Response to ASX Query 5 pages 325.5KB
Regulatory Filings
2022-01-23 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-01-18 English
Immuron Receives AUD $306,154 R&D Tax Concession Refund 2 pages 231.3KB
Regulatory Filings
2022-01-16 English
CURRENT REPORT
Foreign Filer Report
2022-01-13 English
Change in substantial holding 5 pages 906.1KB
Regulatory Filings
2022-01-12 English
Immuron Receives European Patent on Drug to Treat Diarrhea 2 pages 311.1KB
Regulatory Filings
2022-01-12 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-01-12 English
Immuron awarded A$6.2 million US DoD funding for Travelan 3 pages 352.5KB
Regulatory Filings
2022-01-11 English
Change in substantial holding 5 pages 981.7KB
Regulatory Filings
2022-01-05 English